LOTUS EDGE VALVE SYSTEM 10418

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a company representative,foreig report with the FDA on 2020-03-31 for LOTUS EDGE VALVE SYSTEM 10418 manufactured by Boston Scientific Corporation.

Event Text Entries

[187709454] (b)(6) study. It was reported that complete heart block(chb), bradycardia, and atrial fibrillation occurred. Procedure summary: prior to the index procedure, heparin or other anticoagulant was given. The patient received loading doses of 300 mg of aspirin and clopidogrel each. A lotus introducer sheath was placed and then the native aortic valve was treated with balloon valvuloplasty (bav) according to the directions for use. New left bundle branch block (lbbb) was noted post bav. The aortic valve was treated with deployment of a 25 mm lotus edge valve. Successful repositioning of the lotus edge valve involved complete and partial re-sheathing of the lotus edge valve in the delivery system catheter and deployment into a more accurate position within the aortic annulus. Post procedure event summary: three days post index procedure, the patient developed multiple episodes of complete heart block with heart rate at 35-45 beats per minute. Mild symptoms of lightheadedness was noted in the morning. The hospitalization was prolonged due to the event. At this time the block was asymptomatic, however the patient was recommended to start isoprenaline if heart rate was continuously lower than 30. The patient initiated isoprenaline due to symptoms of complete heart block. The following day, the patient was reported to be mildly dizzy with a postural drop at 15 mmhg. Platelets trended low to 96 from 160-200 (standard reference range: 150000- 450000 per microliter of blood) which was diagnosed as thrombocytopenia. Antihypertensive medication was withheld and, on electrophysiology consultation, a permanent pacemaker was recommended to be implanted for new left bundle branch block with intermittent complete heart block. Five days post index procedure, a new permanent pacemaker was successfully implanted and on the same day, the event was considered to be recovered. The electrocardiogram (ecg) report post pacemaker implant showed sinus rhythm with left bundle branch block.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number2134265-2020-03925
MDR Report Key9906902
Report SourceCOMPANY REPRESENTATIVE,FOREIG
Date Received2020-03-31
Date of Report2020-03-31
Date of Event2020-03-14
Date Mfgr Received2020-03-17
Device Manufacturer Date2019-08-27
Date Added to Maude2020-03-31
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactJAY JOHNSON
Manufacturer StreetTWO SCIMED PLACE
Manufacturer CityMAPLE GROVE MN 55311
Manufacturer CountryUS
Manufacturer Postal55311
Manufacturer Phone7634942574
Manufacturer G1BOSTON SCIENTIFIC IRELAND LIMITED
Manufacturer StreetBALLYBRIT BUSINESS PARK
Manufacturer CityGALWAY
Manufacturer CountryEI
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameLOTUS EDGE VALVE SYSTEM
Generic NameLOTUS EDGE TM VALVE SYSTEM
Product CodeNPT
Date Received2020-03-31
Model Number10418
Catalog Number10418
Lot Number0024336163
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerBOSTON SCIENTIFIC CORPORATION
Manufacturer AddressTWO SCIMED PLACE MAPLE GROVE MN 55311 US 55311


Patients

Patient NumberTreatmentOutcomeDate
101. Required No Informationntervention 2020-03-31

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.